2024-04-17 08:00 | UU:BNGO | | News Release200 | Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence |
2024-04-11 08:00 | UU:BNGO | | News Release200 | Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing |
2024-04-04 13:45 | UU:BNGO | | News Release200 | Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules |
2024-04-03 08:00 | UU:BNGO | | News Release200 | Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics |
2024-04-02 08:00 | UU:BNGO | | News Release200 | Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys(TM) System at the American Association for Cancer Research Annual Meeting |
2024-03-19 08:00 | UU:BNGO | | News Release200 | Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance |
2024-03-07 08:00 | UU:BNGO | | News Release200 | Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company's New Stratys(TM) System |
2024-03-05 16:01 | UU:BNGO | | News Release200 | Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024 |
2024-02-29 08:00 | UU:BNGO | | News Release200 | Bionano to Present at TD Cowen's 44th Annual Health Care Conference |
2024-02-28 08:01 | UU:BNGO | | News Release200 | Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024 |
2024-02-28 08:00 | UU:BNGO | | News Release200 | Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway |
2024-02-22 08:00 | UU:BNGO | | News Release200 | American College of Medical Genetics and Genomics Includes OGM in Latest Edition of Technical Laboratory Standards for Solid Tumor Analysis |
2024-01-31 08:00 | UU:BNGO | | News Release200 | Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference |
2024-01-30 08:00 | UU:BNGO | | News Release200 | Bionano ¢ € ™s Symposium 2024 Featured Presentations from its Global User Community Highlighting OGM as a Powerful Alternative to Classical Cytogenetics and Strong Complement to NGS |
2024-01-25 08:00 | UU:BNGO | | News Release200 | Bionano Announces Publication of a Study that Applied OGM to Discovery of Structural Variants Driving Drug Resistance and Sensitivity in Cancer |
2024-01-24 08:00 | UU:BNGO | | News Release200 | Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing |
2024-01-23 08:00 | UU:BNGO | | News Release200 | Bionano Announces Full Commercial Release of the Stratys ¢ „ ¢ System for High Throughput Optical Genome Mapping |
2024-01-19 08:00 | UU:BNGO | | News Release200 | Bionano Announces the Final Speaker Lineup for 2024 Symposium with 33 OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications |
2024-01-11 16:01 | UU:BNGO | | News Release200 | Bionano Announces Peer-Reviewed Publication from its Clinical Study Designed to Support OGM as Part of Standard of Care (SOC) in Genetic Disease Testing |
2024-01-10 08:00 | UU:BNGO | | News Release200 | Bionano Announces 2024 Symposium: Four Consecutive Days of OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications |
2024-01-08 08:00 | UU:BNGO | | News Release200 | Bionano Reports Preliminary Fourth Quarter and ‚ Full-Year 2023 Results |
2024-01-03 08:00 | UU:BNGO | | News Release200 | International Consortium Publishes Comprehensive Roadmap for the Clinical Implementation of OGM in Hematological Malignancy Applications |
2024-01-03 08:00 | UU:BNGO | | News Release200 | OGM Added to International System for Human Cytogenomic Nomenclature |
2023-12-28 08:00 | UU:BNGO | | News Release200 | Bionano Announces Significant Upgrades to its Bionano Solve Pipeline and its VIA ¢ „ ¢ Software for OGM Data Analysis in Constitutional Genetic Disease Research |
2023-12-26 08:00 | UU:BNGO | | News Release200 | Bionano Announces Publication of Largest Prospective Prenatal Study Comparing OGM to Chromosomal Microarray Analysis and Karyotyping |
2023-12-14 08:00 | UU:BNGO | | News Release200 | Cancers Journal Publishes Special Issue Dedicated to OGM ¢ € ™s Impact on Hematological Malignancy Research |
2023-12-12 08:00 | UU:BNGO | | News Release200 | Bionano Laboratories Announces Publication of the Analytical Validation of its OGM-Based Laboratory Developed Test for Hematological Malignancies and Additional Multi-Site Technical Evaluation of OGM |
2023-12-06 08:00 | UU:BNGO | | News Release200 | Bionano Announces Presentations Featuring OGM Utility Across Blood Cancer Research at the American Society of Hematology (ASH) Annual Meeting |
2023-11-30 08:00 | UU:BNGO | | News Release200 | Study Shows that OGM Plays an Important Role in Efficient Diagnosis of FSHD |
2023-11-29 10:04 | UU:BNGO | | News Release200 | Bionano Announces Publication Demonstrating Utility of OGM to Assess Genome Integrity of CRISPR-Edited Cells as Part of Gene Therapy Development |
2023-11-15 00:07 | UU:BNGO | | News Release200 | LeddarTech Appoints Chris Stewart as Chief Financial Officer |
2023-11-14 08:00 | UU:BNGO | | News Release200 | Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting |
2023-11-08 16:01 | UU:BNGO | | News Release200 | Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress |
2023-11-02 08:00 | UU:BNGO | | News Release200 | Thompson and Thompson Genetics and Genomics in Medicine Includes OGM in Latest Edition, Notes Workflow ¢ € ™s Performance and Ability to Detect More SVs than LRS at Lower Cost |
2023-11-01 16:05 | UU:BNGO | | News Release200 | Bionano to Present at the 2023 Stifel Healthcare Conference |
2023-11-01 08:00 | UU:BNGO | | News Release200 | Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023 |
2023-10-26 08:00 | UU:BNGO | | News Release200 | Bionano Announces Presentation of OGM Utility Across Key Applications at the American Society of Human Genetics (ASHG) Annual Meeting |
2023-10-11 08:05 | UU:BNGO | | News Release200 | Bionano Prices $80.0 Million Financing in Convertible Notes and Warrants, Announces Preliminary Q3 2023 Results, and Implements Streamlined Operational Plan |
2023-10-11 08:00 | UU:BNGO | | News Release200 | Bionano Announces Pricing of $80.0 Million Registered Offering and Concurrent Private Placement of Senior Secured Convertible Notes and Warrants |
2023-09-28 08:00 | UU:BNGO | | News Release200 | Benchmarking Study Shows Streamlined Structural Variant Detection and High Concordance for OGM Compared to Chromosomal Microarray Analysis, the Global Standard in Genetic Disease Analysis |
2023-09-22 16:05 | UU:BNGO | | News Release200 | Bionano Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) |
2023-09-21 08:00 | UU:BNGO | | News Release200 | Bionano Announces Third OEM Partner has Received China NMPA Approval for DNA Isolation Products for IVD Use of OGM |
2023-09-14 08:00 | UU:BNGO | | News Release200 | Largest Study of Mendelian Disease Highlights how OGM, alongside other Techniques, May Enhance Success Rates in Identifying Molecular Causes of Genetic Disease |
2023-09-06 08:00 | UU:BNGO | | News Release200 | Bionano Announces Peer-Reviewed Publication on the Utility of Combining OGM and WES for Evaluation of Pediatric Leukemia |
2023-08-30 08:00 | UU:BNGO | | News Release200 | Bionano Announces Publication Demonstrating Utility of OGM as an Alternative to KT and CMA for Evaluating CRISPR-Edited Cells as Part of Stem Cell Therapy Development |
2023-08-28 08:00 | UU:BNGO | | News Release200 | Bionano Announces Second OEM Partner has Received China NMPA Approval for DNA Extraction and Labeling Products for IVD Use of OGM in Reproductive Health |
2023-08-21 16:05 | UU:BNGO | | News Release200 | Bionano Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement |
2023-08-16 08:00 | UU:BNGO | | News Release200 | Bionano Laboratories Receives College of American Pathologists (CAP) Accreditation for its Clinical Laboratory |
2023-08-14 08:00 | UU:BNGO | | News Release200 | Bionano Announces CFO Transition and Appointment of G ƒ ¼lsen Kama as Chief Financial Officer |
2023-08-11 08:00 | UU:BNGO | | News Release200 | Bionano Announces Presentation of Optical Genome Mapping (OGM) Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting |
2023-08-09 16:01 | UU:BNGO | | News Release200 | Bionano Reports Second Quarter 2023 Results and Highlights Recent Business Progress |
2023-08-04 12:00 | UU:BNGO | | News Release200 | Bionano Genomics Announces Reverse Stock Split |
2023-08-02 08:00 | UU:BNGO | | News Release200 | Bionano to Report Second Quarter 2023 Financial Results and Host a Conference Call and Webcast on August 9, 2023 |
2023-07-31 08:00 | UU:BNGO | | News Release200 | Bionano Announces OGM Roadshow, TOUR, which Provides Education on the Company ¢ € ™s Workflow and Helps Build a Community of Users |
2023-07-27 08:00 | UU:BNGO | | News Release200 | Bionano to Present at the Canaccord Genuity 43rd Annual Growth Conference |
2023-06-29 17:10 | UU:BNGO | | News Release200 | Bionano Announces the Stratys ¢ „ ¢ System for OGM and VIA ¢ „ ¢ Software for Hematologic Malignancies |
2023-06-21 09:15 | UU:BNGO | | News Release200 | Bionano to Present at the Healthcare Virtual Conference |
2023-06-20 08:00 | UU:BNGO | | News Release200 | Bionano Announces Peer-Reviewed Publication on the Utility of Combining OGM and a 523-gene NGS Panel for Standard Evaluation of Myeloid Cancers |
2023-06-14 19:19 | UU:BNGO | | News Release200 | Bionano Announces Results from its Annual Meeting of Stockholders |
2023-06-13 08:00 | UU:BNGO | | News Release200 | Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting |
2023-06-12 08:00 | UU:BNGO | | News Release200 | Bionano Announces 2023 Winners of its Innovator Research Grant Program |
2023-06-08 08:00 | UU:BNGO | | News Release200 | Bionano Announces Extensive Lineup of Content at European Conferences Featuring OGM Utility Across a Broad Range of Research Applications |
2023-06-06 08:00 | UU:BNGO | | News Release200 | Bionano Announces Commercial Release of New Kits for its Ionic System featuring New Chemistry for Nucleic Acid Extraction from FFPE and Tumor Tissue |
2023-05-09 16:01 | UU:BNGO | | News Release200 | Bionano Reports First Quarter 2023 Results and Highlights Recent Business Progress |
2023-05-02 08:00 | UU:BNGO | | News Release200 | Bionano to Report First Quarter 2023 Financial Results and Host a Conference Call and Webcast on May 9, 2023 |
2023-05-01 19:51 | UU:BNGO | | News Release200 | Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal |
2023-04-26 08:00 | UU:BNGO | | News Release200 | Bionano Announces Three Publications Demonstrating OGM ¢ € ™s Utility for Hematological Malignancy Research |
2023-04-24 09:55 | UU:BNGO | | News Release200 | UPDATE - Bionano Announces Preliminary Q1 2023 Results and Business Updates |
2023-04-24 08:00 | UU:BNGO | | News Release200 | Bionano Announces Preliminary Q1 2023 Results and Business Updates |